Valued at 350M by which company? 10 year data is great but why can't we get financial support based on the data? Also MRK is positive but if it's that important how come they don't try to expedite recruitment (29 people) and finance the clinical trial ?

https://clinicaltrials.gov/ct2/show/record/NC...amp;rank=1